Nifedipine or labetalol for hypertension in pregnancy
Authors:
- 21 October 2025
- journal article
- Published by BMJ in Drug and Therapeutics Bulletin
- Vol. 63 (12) , 179-181
Abstract
Commentary on: Sanusi AA, Leach J, Boggess K, et al . Pregnancy Outcomes of Nifedipine Compared With Labetalol for Oral Treatment of Mild Chronic Hypertension. Obstet Gynecol. 2024;144:126-134. Series Editor: Dr Teck Khong, DTB Associate Editor, Clinical Pharmacology, St George’s, University of London, UKKeywords
This publication has 7 references indexed in Scilit:
- Pregnancy Outcomes of Nifedipine Compared With Labetalol for Oral Treatment of Mild Chronic HypertensionObstetrics & Gynecology, 2024
- A treatment strategy with nifedipine versus labetalol for women with pregnancy hypertension: study protocol for a randomised controlled trial (Giant PANDA)Trials, 2023
- A Critical Review of Medication Adherence in Hypertension: Barriers and Facilitators Clinicians Should ConsiderPatient Preference and Adherence, 2022
- Treatment for Mild Chronic Hypertension during PregnancyNew England Journal of Medicine, 2022
- Hypertension in Pregnancy: Diagnosis, Blood Pressure Goals, and Pharmacotherapy: A Scientific Statement From the American Heart AssociationHypertension, 2021
- Labetalol Versus Nifedipine as Antihypertensive Treatment for Chronic Hypertension in PregnancyHypertension, 2017
- Discontinuation of and changes in drug therapy for hypertension among newly-treated patients: a population-based study in ItalyJournal Of Hypertension, 2008